Search

Search bills, members, committees and pages...

AKSHAI DATTA

15 federal lobbying filings, 2023 to 2026.

AKSHAI DATTA is a registered lobbyist named on 15 federal lobbying filings, 2023 to 2026.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

1 they have filed under, by filings.

RegistrantFilingsReported
ASTELLAS PHARMA US, INC.15

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262$1.1M
20254$3.1M
20244$3.1M
20235$2.2M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
CPTCopyright/Patent/Trademark15
HCRHealth Issues15
MMMMedicare/Medicaid15
INSInsurance8
TAXTaxation/Internal Revenue Code5

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1300PSA Screening for HIM Act6
S. 297PSA Screening for HIM Act6
H.R. 5376Impacts and Outcomes for Health Career Training Act1
S. 392Sloan Canyon Conservation and Lateral Pipeline Act1

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
ASTELLAS PHARMA US, INC.ASTELLAS PHARMA US, INC.2026 second_quarter$510KJul 20, 2026
ASTELLAS PHARMA US, INC.ASTELLAS PHARMA US, INC.2026 first_quarter$590KApr 20, 2026
ASTELLAS PHARMA US, INC.ASTELLAS PHARMA US, INC.2025 fourth_quarter$980KJan 20, 2026
ASTELLAS PHARMA US, INC.ASTELLAS PHARMA US, INC.2025 third_quarter$850KOct 20, 2025
ASTELLAS PHARMA US, INC.ASTELLAS PHARMA US, INC.2025 second_quarter$670KJul 21, 2025
ASTELLAS PHARMA US, INC.ASTELLAS PHARMA US, INC.2025 first_quarter$560KApr 21, 2025
ASTELLAS PHARMA US, INC.ASTELLAS PHARMA US, INC.2024 fourth_quarter$670KJan 20, 2025
ASTELLAS PHARMA US, INC.ASTELLAS PHARMA US, INC.2024 third_quarter$670KOct 18, 2024
ASTELLAS PHARMA US, INC.ASTELLAS PHARMA US, INC.2024 second_quarter$770KJul 19, 2024
ASTELLAS PHARMA US, INC.ASTELLAS PHARMA US, INC.2024 first_quarter$960KApr 22, 2024
ASTELLAS PHARMA US, INC.ASTELLAS PHARMA US, INC.2023 fourth_quarter$440KJan 19, 2024
ASTELLAS PHARMA US, INC.ASTELLAS PHARMA US, INC.2023 third_quarter$620KOct 20, 2023
ASTELLAS PHARMA US, INC.ASTELLAS PHARMA US, INC.2023 second_quarter$590KJul 20, 2023
ASTELLAS PHARMA US, INC.ASTELLAS PHARMA US, INC.2023 first_quarter$590KApr 20, 2023
ASTELLAS PHARMA US, INC.ASTELLAS PHARMA US, INC.2023 second_quarterApr 10, 2023